Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
May 12, 2020	8-K	Report of unscheduled material events or corporate event	0001193125-20-140443.pdf 0001193125-20-140443.rtf 0001193125-20-140443.xls View HTML
May 11, 2020	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	0001193125-20-139011.pdf 0001193125-20-139011.rtf 0001193125-20-139011.xls View HTML
May 5, 2020	8-K	Report of unscheduled material events or corporate event	0001193125-20-133106.pdf 0001193125-20-133106.rtf 0001193125-20-133106.xls View HTML
May 5, 2020	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001564590-20-021255.pdf 0001564590-20-021255.rtf 0001564590-20-021255.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
April 24, 2020	CT ORDER	CT ORDER	View HTML
April 24, 2020	UPLOAD	UPLOAD	View HTML
April 23, 2020	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-20-117181.pdf 0001193125-20-117181.rtf 0001193125-20-117181.xls View HTML
April 23, 2020	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-20-117193.pdf 0001193125-20-117193.rtf 0001193125-20-117193.xls View HTML
April 20, 2020	8-K	Report of unscheduled material events or corporate event	0001193125-20-111645.pdf 0001193125-20-111645.rtf 0001193125-20-111645.xls View HTML
April 15, 2020	PRER14A	Proxy soliciting materials. Revised preliminary material	0001193125-20-107370.pdf 0001193125-20-107370.rtf 0001193125-20-107370.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax